Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05370339 · ClinicalTrials.gov registry record
Assessment of Sleep and Sleep Disruptors in Adolescents With Type 1 Diabetes
A clinical trial of Type 1 Diabetes and Insufficient Sleep, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 70
- Enrollment target
- 1
- Study location
NCT05370339 is a study of Type 1 Diabetes and Insufficient Sleep that has completed, run by University of Colorado, Denver. The registered enrollment target is 70 participants, below the 824-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05370339, a study of Type 1 Diabetes and Insufficient Sleep, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to identify causes of insufficient sleep and sleep disruptors in adolescents with type 1 diabetes. For this study, adolescents will wear an actigraphy watch and complete sleep diaries for seven days. On completion of the seven days, they will complete several questionnaires regarding sleep, fear of hypoglycemia, and anxiety and depression. A subset of participants will additionally complete a qualitative interview session to obtain a deeper understanding of sleep disruptors and barriers and facilitators to improving sleep health.
Conditions Studied
Study Locations (1)
Colorado
- University of Colorado, Barbara Davis Center - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2022-06-15 |
| Est. Completion | 2023-08-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05370339
The ClinicalTrials.gov registry entry for NCT05370339 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 824-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (92% lower). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Type 1 Diabetes appearing as the primary indexed condition, and to 0 interventions.
NCT05370339 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT05370339 about?
NCT05370339 is a clinical study titled "Assessment of Sleep and Sleep Disruptors in Adolescents With Type 1 Diabetes". The goal of this study is to identify causes of insufficient sleep and sleep disruptors in adolescents with type 1 diabetes. For this study, adolescents will wear an actigraphy watch and complete sleep diaries for seven days. On completion of the seven days, they will complete several questionnaires...
What is the current status of trial NCT05370339?
This trial is currently completed. The enrollment target is 70 participants. The study started on 2022-06-15. Estimated completion is 2023-08-30.
What conditions does trial NCT05370339 study?
This clinical trial studies the following conditions: Type 1 Diabetes, Insufficient Sleep.
Who is sponsoring clinical trial NCT05370339?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05370339 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 1 Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes
RECRUITING · Phase 1
-
Multivariable Artificial Pancreas: Detecting and Mitigating Unannounced Physical Activity and Acute Psychological Stress
RECRUITING
-
Extended Bolus for Meals in a Closed-loop System
RECRUITING · Phase 4
-
REAL-Fam Feasibility Study for Youth Diabetes Management
RECRUITING · NA
-
A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus
RECRUITING · Phase 1
-
AIDANET Pediatrics
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.